MPM Score Calculator
Calculate ICU admission mortality probability using the validated Mortality Probability Model (MPM0 II). Enter the 13 clinical variables to generate a hospital mortality probability estimate with risk zone classification and variable contribution analysis.
This calculator is provided for informational and educational purposes only. It is not intended to replace professional medical advice, diagnosis, or treatment. Always consult with a qualified healthcare professional before making any medical decisions. The results from this calculator should be used as a reference guide only and not as the sole basis for clinical decisions.
<10%
10-25%
25-50%
50-75%
>75%
MPM Severity Reference – Risk Zones and Clinical Guidance
| Probability Range | Risk Category | Expected Outcome Pattern | Recommended Action |
|---|---|---|---|
| 0% – 10% | Low Risk | Most patients in this stratum survive to hospital discharge | Routine ICU monitoring; standard care protocols |
| 10% – 25% | Moderate Risk | Elevated acuity; majority survive with appropriate treatment | Careful monitoring; early treatment response assessment |
| 25% – 50% | High Risk | Approximately 1 in 3 to 1 in 2 similar patients do not survive | Early goals-of-care discussion; consider palliative care referral |
| 50% – 75% | Very High Risk | Majority of patients with this profile do not survive to discharge | Advanced care planning; palliative care consultation appropriate |
| Above 75% | Extreme Risk | Very high predicted mortality; few patients with this profile survive | Urgent goals-of-care discussion; review treatment intensity |
Note: These risk zone thresholds are clinical interpretation guides and are not formally defined in the original MPM0 II publication (Lemeshow et al., 1993). Individual patient outcomes vary substantially within each zone. The MPM score is a population-level statistical estimate and must not be used as the sole basis for clinical decision-making.
MPM0 II Logistic Regression Coefficients (Lemeshow et al., 1993)
| Variable | Type | Coefficient | Active in Current Input |
|---|---|---|---|
| Intercept | Constant | -5.46836 | Always |
| Age (per year) | Continuous | 0.03057 | – |
| Heart Rate above 150 bpm | Binary | 0.76124 | No |
| Systolic BP below 90 mmHg | Binary | 0.89105 | No |
| Acute Renal Failure | Binary | 0.94394 | No |
| Coma or Deep Stupor (GCS 3-5) | Binary | 1.19979 | No |
| Chronic Renal Insufficiency | Binary | 0.63695 | No |
| Hepatic Cirrhosis | Binary | 0.97672 | No |
| Metastatic Neoplasm | Binary | 1.19979 | No |
| Medical ICU Admission | Binary | 0.57720 | No |
| Emergency Surgery | Binary | 0.72654 | No |
| CPR Prior to Admission | Binary | 1.25214 | No |
| Intracranial Mass Effect | Binary | 0.22778 | No |
| Logit Sum (L) | — | P = — | |
Source: Lemeshow S, Teres D, Klar J, et al. Mortality Probability Models (MPM II) based on an international cohort of intensive care unit patients. JAMA. 1993;270(20):2478-2486. AUC approximately 0.82 in derivation cohort.
Standardised Mortality Ratio (SMR) – ICU Benchmarking Reference
| SMR Value | Interpretation | Implication | Typical Action |
|---|---|---|---|
| Below 0.75 | Significantly better than expected | Observed mortality substantially lower than MPM-predicted; strong quality signal | Document practices; share learnings; verify data quality |
| 0.75 – 0.90 | Better than expected | Above-average performance for the case mix | Continue quality monitoring; identify contributing factors |
| 0.90 – 1.10 | As expected | Outcomes consistent with predicted mortality for patient mix | Routine quality monitoring; maintain standards |
| 1.10 – 1.25 | Slightly worse than expected | Modest excess mortality; warrants investigation | Review processes; consider quality improvement initiatives |
| Above 1.25 | Significantly worse than expected | Substantial excess mortality; quality concern | Formal quality review; root cause analysis; intervention planning |
Always report SMR with 95% confidence intervals. Institutional SMR interpretation requires recalibration of the MPM model against local data every 3 to 5 years, as the original MPM0 II coefficients may overestimate mortality in contemporary ICU populations relative to the 1993 derivation cohort.
About This MPM Score Calculator
This MPM score calculator implements the Mortality Probability Model II (MPM0 II), designed for intensive care physicians, critical care nurses, clinical researchers, and ICU quality improvement professionals. It calculates the hospital mortality probability for adult ICU patients based on 13 clinical variables available at the time of admission, producing a predicted mortality percentage using validated logistic regression coefficients from Lemeshow et al. (1993).
The calculator applies the MPM0 II formula – intercept of -5.46836 plus the weighted sum of patient variables – then converts the logit to a probability using the standard logistic function. Variables are grouped into five clinical categories (vital signs, neurological status, renal function, chronic disease history, and admission circumstances) following the original model structure. Coefficients are taken directly from the JAMA 1993 publication and have not been modified. The tool is appropriate for adult general ICU populations; it is not validated for paediatric patients or as a triage tool for ICU admission decisions.
The gradient risk zone bar shows at a glance where this patient falls across the five mortality strata, while the variable contribution chart ranks each active factor by its logit coefficient. The MPM Severity Reference tab provides clinical action guidance for each risk zone. The Coefficient Table tab updates dynamically to confirm which variables are active and shows the current logit and probability. The SMR Benchmarking Guide explains how to interpret institutional standardised mortality ratios derived from pooled MPM predictions. Consult a qualified intensivist or critical care specialist for all clinical decisions.
This calculator is provided for informational and educational purposes only. It is not intended to replace professional medical advice, diagnosis, or treatment. Always consult with a qualified healthcare professional before making any medical decisions. The results from this calculator should be used as a reference guide only and not as the sole basis for clinical decisions. The MPM score represents a population-level statistical estimate derived from a 1993 cohort and cannot predict individual patient outcomes.
MPM Score Calculator – Mortality Probability Model for ICU Risk Assessment
The Mortality Probability Model (MPM) is a validated scoring system used in intensive care units worldwide to estimate the probability of hospital mortality for critically ill patients. Unlike diagnosis-specific tools, the MPM applies across a broad population of ICU admissions, making it one of the most versatile prognostic instruments in critical care medicine. Clinicians, researchers, and hospital administrators rely on MPM scores to benchmark performance, support clinical decision-making, and stratify patients by acuity at admission and throughout their ICU stay.
This calculator implements the MPM0 II (admission) model, which generates a mortality probability estimate based on data available at the time of ICU admission – before substantial treatment has been rendered. The score does not direct individual care decisions but provides a population-level risk estimate that contextualises outcomes and supports transparent communication between clinical teams and families.
Background and Development of the Mortality Probability Model
The MPM was originally developed by Stanley Lemeshow and colleagues in the early 1980s as part of a broader effort to create objective, statistically derived tools for ICU outcome prediction. The first generation, MPM0 (admission model) and MPM24 (24-hour model), were derived from a prospective cohort study and published in 1985. These early models established the principle of using logistic regression to translate clinical variables into a probability of death.
The second generation – MPM0 II – was published in 1993 using data from the APACHE III study cohort. It refined the variable selection and updated coefficients to reflect contemporary ICU practice. MPM0 II uses 15 variables collected at admission, all of which are routinely available without additional laboratory testing or complex physiological measurement. This pragmatic design contributed significantly to its widespread adoption.
Subsequent work led to MPM0 III, published in 2005 by Higgins and colleagues, using data from Project IMPACT. MPM0 III updated the model for a larger and more diverse patient population, introduced updated coefficients, and removed the 24-hour and 48-hour variants. This calculator primarily implements the MPM0 II framework, as it remains the most widely cited and validated version in the published literature.
Clinical Variables Used in MPM0 II
MPM0 II uses 15 binary (yes/no) predictor variables, each derived from information available at or before ICU admission. The variables fall into three conceptual categories: acute physiological findings, chronic health conditions, and admission characteristics.
Acute physiological and clinical variables:
- Age (continuous, used directly)
- Heart rate over 150 beats per minute at admission
- Systolic blood pressure below 90 mmHg at admission
- Acute renal failure (creatinine over 2.0 mg/dL in the absence of chronic renal failure)
- Coma or deep stupor at admission (Glasgow Coma Scale 3 to 5)
Chronic disease variables:
- Chronic renal insufficiency
- Hepatic cirrhosis
- Metastatic neoplasm
Admission type and diagnosis variables:
- Medical admission (versus surgical)
- Emergency surgery (unplanned surgical admission)
- Resuscitation from cardiac arrest prior to admission
- Intracranial mass effect (confirmed on imaging or clinical diagnosis)
- Internal medical or surgical reason for admission
Each variable is assigned a coefficient derived from the logistic regression model. The sum of these weighted terms, combined with an intercept, is then transformed using the logistic function to produce a probability between 0 and 1, representing the estimated likelihood of hospital death.
P = estimated probability of hospital mortality (0.0 to 1.0)
e = Euler’s number (approximately 2.718)
Variables are binary (0 or 1) except age, which is continuous.
MPM0 II Coefficients and Variable Weights
The following table presents the logistic regression coefficients for each variable in the MPM0 II model as published by Lemeshow et al. (1993). These coefficients were derived from a dataset of 19,124 ICU admissions across multiple academic and community hospitals in the United States.
| Variable | Coefficient |
|---|---|
| Intercept | -5.46836 |
| Age (per year) | 0.03057 |
| Heart rate above 150 bpm | 0.76124 |
| Systolic BP below 90 mmHg | 0.89105 |
| Acute renal failure | 0.94394 |
| Coma or deep stupor (GCS 3-5) | 1.19979 |
| Chronic renal insufficiency | 0.63695 |
| Hepatic cirrhosis | 0.97672 |
| Metastatic neoplasm | 1.19979 |
| Medical ICU admission | 0.57720 |
| Emergency surgery | 0.72654 |
| CPR prior to admission | 1.25214 |
| Intracranial mass effect | 0.22778 |
Interpreting the MPM Score
The MPM0 II output is a probability expressed as a percentage. A score of 20% means that, in a large population of patients with the same combination of risk factors, approximately 20 in 100 would be expected to die before hospital discharge. It does not mean a specific individual patient has a 20% chance of death – individual outcomes are inherently binary, and the model cannot predict for any single person.
The MPM score is a population-level statistical estimate, not an individual prognosis. A score of 80% does not mean a patient will die, nor does a score of 5% guarantee survival. Clinical judgment, goals of care discussions, and evolving clinical status must always accompany any prognostic score.
The following risk categories provide a practical interpretation framework, though these thresholds are not formally defined in the original publication:
| Probability Range | Risk Category | Clinical Context |
|---|---|---|
| 0 – 10% | Low risk | Routine ICU monitoring expected; most patients survive |
| 10 – 25% | Moderate risk | Elevated acuity; careful monitoring and treatment response assessment |
| 25 – 50% | High risk | Significant illness burden; early goals-of-care discussion appropriate |
| 50 – 75% | Very high risk | Majority of similar patients do not survive; advanced care planning important |
| Above 75% | Extreme risk | Very high predicted mortality; consider palliative care consultation |
MPM Compared to Other ICU Scoring Systems
Intensive care medicine uses several validated scoring systems, each with distinct design principles and intended applications. Understanding the differences helps clinicians choose the right tool for a given purpose.
APACHE II and APACHE IV: The Acute Physiology and Chronic Health Evaluation systems use up to 12 physiological variables measured in the first 24 hours of ICU admission, plus age and chronic health points. APACHE is more granular than MPM for physiological derangement but requires laboratory data and the worst values within the first 24 hours, making it less practical for immediate admission use. APACHE IV is diagnosis-specific and offers superior calibration for defined diagnostic groups.
SAPS II and SAPS 3: The Simplified Acute Physiology Score uses 17 variables over the first 24 hours. SAPS 3 was derived from a large international dataset and includes pre-ICU hospital location and reason for ICU admission, offering good performance across diverse healthcare systems globally.
SOFA Score: The Sequential Organ Failure Assessment score quantifies the degree of organ dysfunction across six systems and is designed for serial assessment throughout the ICU stay. SOFA is primarily a severity-of-illness and trajectory tracker rather than an admission mortality predictor.
Where MPM stands out: The admission MPM (MPM0 II) is unique in requiring no laboratory values and no physiological measurement beyond vital signs. This makes it particularly practical in resource-limited settings, for real-time clinical summaries, and for rapid risk stratification before laboratory results are available.
Calibration, Discrimination, and Model Performance
Prognostic models are evaluated on two main dimensions: discrimination and calibration.
Discrimination refers to a model’s ability to rank patients correctly – that is, to assign higher predicted probabilities to patients who die than to those who survive. It is typically quantified by the area under the receiver operating characteristic (ROC) curve, commonly called the C-statistic or AUC. MPM0 II reports an AUC of approximately 0.82 in its derivation dataset, indicating good discriminatory ability.
Calibration refers to the agreement between predicted probabilities and observed mortality rates across risk strata. A well-calibrated model predicts 30% mortality in patients with 30% predicted probability. Calibration is assessed using the Hosmer-Lemeshow goodness-of-fit test. MPM0 II demonstrated acceptable calibration in its original validation cohort; however, subsequent external validations – particularly in non-North American populations – have shown variable calibration, reflecting temporal and geographic shifts in ICU case mix and treatment standards.
All ICU scoring models were derived from historical cohorts. Advances in mechanical ventilation, sepsis management, and other interventions have changed observed mortality rates over time. This “temporal drift” means models tend to overestimate mortality when applied to contemporary ICU populations. Institutional recalibration is periodically recommended for quality benchmarking purposes.
Appropriate Clinical Uses of the MPM Score
The MPM is best used in the following contexts:
ICU performance benchmarking: By comparing observed mortality to predicted mortality (the standardised mortality ratio, or SMR), hospital systems can assess whether their outcomes are better or worse than expected for their patient mix. An SMR below 1.0 suggests better-than-predicted outcomes; above 1.0 suggests worse-than-predicted outcomes, prompting quality improvement review.
Clinical research stratification: Clinical trials and observational studies use MPM scores to ensure comparability between patient groups and to control for baseline mortality risk in statistical analyses.
Resource allocation and triage: In situations of resource scarcity, objective acuity measures including MPM scores can supplement clinical judgment in triage decisions, though they should never be the sole basis for withholding care.
Goals-of-care discussions: When shared with patients’ families using appropriate framing, predicted mortality probabilities can help families understand the severity of illness and support informed decision-making about intensity of care.
Limitations of the MPM Score
The MPM, like all prognostic models, carries inherent limitations that every clinician should understand before applying it.
Population-level inference: The score predicts outcomes for groups of patients, not for individuals. A 60% predicted mortality means 40 out of 100 similar patients survive – outcomes vary substantially at the individual level.
Derivation cohort limitations: MPM0 II was derived from a predominantly North American dataset from the late 1980s and early 1990s. Case mix, treatment protocols, and patient demographics have changed substantially since then. The model may not calibrate well in all contemporary populations.
Missing variable granularity: The binary nature of most MPM variables (yes/no) sacrifices the nuance available from continuous measurements. For example, a systolic blood pressure of 85 mmHg and 50 mmHg both count as “below 90 mmHg” and receive the same score, despite the significant clinical difference between them.
Not designed for individual prognosis: Using the MPM to communicate an individual prognosis to patients or families – for example, saying “you have a 70% chance of dying” – is inappropriate and potentially harmful. Prognostic models should inform, not replace, nuanced clinical communication.
Does not capture treatment response: The admission MPM0 reflects risk at a single point in time. It does not account for clinical trajectory, response to treatment, or evolving complications. Serial tools such as SOFA are more appropriate for dynamic monitoring.
The MPM score should never be used as the sole basis for clinical decisions, including decisions to withdraw life-sustaining treatment. It is a statistical estimate based on population data and cannot predict individual outcomes. All decisions must integrate clinical assessment, patient preferences, family input, and institutional ethics frameworks.
Global Application and Population Considerations
The MPM was developed and validated primarily in North American academic medical centers, but it has been studied in patient populations across Europe, Asia, South America, and the Middle East. External validation studies have generally confirmed acceptable discrimination (AUC 0.75 to 0.85) across diverse populations, though calibration varies more widely.
Studies in European ICUs have generally found that MPM0 II overestimates mortality, likely reflecting improvements in sepsis management and organ support since the model was derived. Validations in South Asian and East Asian populations have shown similar patterns, with some groups reporting moderate underestimation of mortality in patients with specific diagnoses such as tropical infections or post-cardiac surgery admissions.
The European Society of Intensive Care Medicine (ESICM) and the Society of Critical Care Medicine (SCCM) both acknowledge the MPM family as validated prognostic tools while emphasising the need for local calibration when used for institutional benchmarking. The World Federation of Societies of Intensive and Critical Care Medicine (WFSICCM) has highlighted the practical value of MPM in lower-resource settings where laboratory infrastructure for APACHE-based scoring may be unavailable.
Several regional adaptations and recalibrations of the MPM framework have been published, including models specifically derived from Indian, Brazilian, and Chinese ICU cohorts. These regional models generally demonstrate improved calibration over the original North American derivation when applied locally.
Worked Example: Calculating MPM0 II
A 72-year-old patient is admitted to the medical ICU following a ruptured abdominal aortic aneurysm with emergency surgery. On admission: heart rate 160 bpm, systolic blood pressure 78 mmHg, no prior renal disease or cirrhosis, no known malignancy, no coma (GCS 14), no prior CPR, no intracranial pathology.
Variable scoring:
- Age: 72 (continuous – contributes 72 x 0.03057 = 2.201)
- Heart rate above 150: Yes (+0.76124)
- Systolic BP below 90: Yes (+0.89105)
- Emergency surgery: Yes (+0.72654)
- Medical admission: No (0)
- All other variables: No (0)
Logit (L): -5.46836 + 2.201 + 0.76124 + 0.89105 + 0.72654 = -0.869
Probability: e^(-0.869) / (1 + e^(-0.869)) = 0.419 / 1.419 = approximately 29.5%
Interpretation: High risk – approximately 30% estimated probability of hospital mortality. Goals-of-care discussion is appropriate given the clinical context.
MPM Score and ICU Quality Improvement
The primary institutional application of MPM is in quality improvement through standardised mortality ratios (SMR). The SMR is calculated by dividing observed deaths by expected deaths (sum of individual MPM predicted probabilities) within a defined period or patient group.
SMR below 1.0: Fewer deaths than predicted (better-than-expected outcomes)
SMR above 1.0: More deaths than predicted (worse-than-expected outcomes; warrants review)
Confidence intervals should always accompany SMR estimates.
The SMR has limitations. It is sensitive to the accuracy of the underlying prediction model’s calibration in the local population. If the model systematically overestimates mortality (common in modern ICUs), even an average-performing unit will appear to have an SMR below 1.0. This is why periodic recalibration of the prediction model against local observed data is recommended before drawing conclusions from SMR analyses.
Ethical Considerations in Prognostic Scoring
Prognostic scores can improve care when used appropriately, but they carry ethical risks when misapplied. The key ethical principles relevant to MPM use are:
Non-maleficence: A high MPM score should not automatically trigger withdrawal of treatment. The score reflects population-level statistics; individual patients with identical scores experience widely varying outcomes depending on factors the model does not capture.
Autonomy: Prognostic information, when shared with patients or families, should be communicated using absolute numbers, frequencies, and ranges rather than single probability figures. Saying “most patients with this combination of findings do not survive to hospital discharge, but some do” is more informative and less harmful than stating a percentage.
Justice: In triage situations, standardised objective scoring may help reduce disparities in care allocation driven by implicit bias. However, model performance may differ across demographic groups, and uncritical reliance on any scoring system without awareness of its derivation population can perpetuate inequity.
Beneficence: When MPM scores prompt early palliative care consultation or honest goals-of-care conversations in high-risk patients, they serve patient-centred care and can reduce unnecessary suffering at the end of life.
Frequently Asked Questions
Conclusion
The Mortality Probability Model is a well-validated, practically designed tool for estimating ICU admission mortality risk based on variables available at the bedside without laboratory testing. Its strengths lie in simplicity, transparency, and an extensive international validation record. Its limitations – particularly temporal calibration drift and binary variable coding – are well understood and should inform its use.
When applied appropriately in quality benchmarking, clinical research, and informed goals-of-care discussions, the MPM contributes meaningfully to evidence-based critical care practice. It should always be interpreted alongside clinical judgment, patient preferences, and evolving clinical trajectory. No scoring system – however well designed – replaces the nuanced, individualised assessment that defines excellent intensive care medicine.
Always consult a qualified intensivist or critical care physician when making clinical decisions about ICU patients. This calculator is intended as an educational and research reference tool only.